The Prevent Severe COVID-19 (PRESECO) Study

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Double-blinded, placebo control, randomized, phase-3 clinical trial to evaluate clinical efficacy of Favipiravir in patients with mild to moderate symptoms related to COVID-19 infection
Epistemonikos ID: c181cc7d805af2599ecb46e2be07b1c1e8c197d9
First added on: Oct 24, 2020